Linde J, Friis T
Acta Endocrinol (Copenh). 1979 Jul;91(3):437-48. doi: 10.1530/acta.0.0910437.
The degree of osteoporosis in hyperthyroidism before and during treatment with carbimazole was studied by photon absorption technique of the right forearm and calcaneus. In addition serum total calcium, serum ionized calcium, serum phosphorus and serum alkaline phosphatase were determined. A group of 96 patients suffering from untreated hyperthyroidism (85 women and 11 men) was studied (79 of these patients were also followed during treatment) and compared to a control group of 157 persons (107 women and 50 men). The women were divided into two groups: less than or equal to 45 years old and more than 45 years old. In all groups untreated hyperthyroid patients showed lower bone densities compared to the control group, but this was only significant in women. During treatment all groups showed a significant increase in density. After 3-6 months of treatment bone density in the calcaneus increased 12% and in the forearm 1.5%; after 6 months - 3 years 33% and 31%, respectively. At that time bone density was normalized. There was no correlation between bone density in hyperthyroid patients and duration and severity of the disease. The biochemical changes were characterised by increases in serum alkaline phosphatase (26%), serum total calcium (16%) and serum ionized calcium concentration (17%) in cases of untreated hyperthyroidism. Serum phosphorus concentration did not change. A correlation was found between elevation of the alkaline phosphatase and decreased bone density.
采用右前臂和跟骨的光子吸收技术,研究了甲亢患者在使用卡比马唑治疗前及治疗期间的骨质疏松程度。此外,还测定了血清总钙、血清离子钙、血清磷和血清碱性磷酸酶。对一组96例未经治疗的甲亢患者(85例女性和11例男性)进行了研究(其中79例患者在治疗期间也接受了随访),并与157人的对照组(107例女性和50例男性)进行了比较。女性被分为两组:年龄小于或等于45岁和大于45岁。在所有组中,未经治疗的甲亢患者与对照组相比骨密度较低,但仅在女性中具有显著性差异。治疗期间所有组的骨密度均显著增加。治疗3 - 6个月后,跟骨骨密度增加12%,前臂增加1.5%;6个月至3年后,分别增加33%和31%。此时骨密度恢复正常。甲亢患者的骨密度与疾病持续时间和严重程度之间无相关性。未经治疗的甲亢患者生化变化的特征是血清碱性磷酸酶升高(26%)、血清总钙升高(16%)和血清离子钙浓度升高(17%)。血清磷浓度未发生变化。发现碱性磷酸酶升高与骨密度降低之间存在相关性。